Tandem Diabetes Care (TNDM) Enterprise Value (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Enterprise Value of -$570.3 million for Q1 2026, down 94.85% on a QoQ basis from -$292.7 million in Q4 2025, and down 54.7% year-over-year from -$1.3 billion in Q1 2025.
Tandem Diabetes Care (TNDM) Enterprise Value (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Enterprise Value history runs 14 years deep, the most recent figure standing at -$570.3 million for Q1 2026.
- Quarterly Enterprise Value fell 54.7% year-over-year to -$570.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$570.3 million (down 54.7% YoY) and the FY2025 annual result came in at -$292.7 million, up 33.23% from the prior year.
- Enterprise Value was -$570.3 million for Q1 2026 at Tandem Diabetes Care, down from -$292.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$292.7 million in Q4 2025 and bottomed at -$635.4 million in Q1 2022.
- A 5-year average of -$481.6 million and a median of -$473.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value surged 33.23% — and 2026, when it tumbled 54.7%.
- Tandem Diabetes Care's Enterprise Value stood at -$616.9 million in 2022, then increased by 24.15% to -$467.9 million in 2023, then grew by 6.32% to -$438.3 million in 2024, then jumped by 33.23% to -$292.7 million in 2025, then sank by 94.85% to -$570.3 million in 2026.
- Business Quant data shows TNDM's Enterprise Value at -$570.3 million in Q1 2026, -$292.7 million in Q4 2025, and -$319.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | -570.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -570.26 Mn |
| Dec 31, 2025 | -292.67 Mn |
| Sep 30, 2025 | -319.11 Mn |
| Jun 30, 2025 | -315.36 Mn |
| Mar 31, 2025 | -368.63 Mn |
| Dec 31, 2024 | -438.33 Mn |
| Sep 30, 2024 | -473.31 Mn |
| Jun 30, 2024 | -452.42 Mn |
| Mar 31, 2024 | -467.81 Mn |
| Dec 31, 2023 | -467.91 Mn |
| Sep 30, 2023 | -498.16 Mn |
| Jun 30, 2023 | -507.25 Mn |
| Mar 31, 2023 | -519.59 Mn |
| Dec 31, 2022 | -616.90 Mn |
| Sep 30, 2022 | -608.73 Mn |
| Jun 30, 2022 | -635.33 Mn |
| Mar 31, 2022 | -635.39 Mn |
| Dec 31, 2021 | -623.81 Mn |
| Sep 30, 2021 | -594.99 Mn |
| Jun 30, 2021 | -545.30 Mn |